Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 693
Selected: 0
NCT IDTitle
NCT00882362Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT05650320To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
NCT01987960Brexpiprazole as an Adjunctive Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD)
NCT01670279Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
NCT00064441FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
NCT01076322A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
NCT00095758A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
NCT03386851Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
NCT01895322Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
NCT04186403Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
NCT02476409Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders
NCT03487198The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
NCT03257865A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
NCT01074710Safety and Pharmacokinetic Study of C13-URA in Healthy Volunteers
NCT00329810Effect on Cognitive Function of a Treatment With Aripiprazole
NCT02968121Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
NCT00362271Aripiprazole and Effexor XR Drug Interaction Study
NCT00080327Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
NCT00463151An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
NCT01280721A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan]
NCT02196506Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
NCT03342963Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults
NCT01870999A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
NCT03854409A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
NCT03487770Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder
NCT03734354The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects
NCT01940159A Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia
NCT03303079Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine
NCT07053891LUPKYNIS Drug-use Results Survey
NCT01438060Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type
NCT00064454FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis
NCT02006654Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
NCT01131351Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis
NCT00318253The Effects of Cranberry Juice on Bacterial Adhesion
NCT01939353Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
NCT02225067Comparison Study Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring
NCT04244253A Phase 2 Trial of OPC-64005 for Major Depressive Disorder
NCT02069119A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)
NCT00130039Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
NCT00201981Study of Rebamipide Eye Drops to Treat Dry Eye
NCT07166887Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male
NCT02293993Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
NCT06674291Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)
NCT01349348Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
NCT00036348Study of Aripiprazole in Patients With a History of Bipolar Disorder
NCT00520650Health Evaluation of Abilify Long-term Therapy
NCT01663662The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
NCT00479336A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema
NCT05759819Evaluate the Efficacy and Safety of the Cilostazol-coated BioMimics 3D Stent System in Patients with Peripheral Arterial Occlusive Disease
NCT01413178A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma